AMRN FY 2024 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$229M-25.5% YoY

Gross Profit

$81M35.6% margin

Operating Income

-$92M-40.2% margin

Net Income

-$82M-35.9% margin

EPS (Diluted)

$-4.00

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$31M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$685M

Total Liabilities

$199M

Stockholders' Equity

$486M

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$229M	$307M	-25.5%
Gross Profit	$81M	$166M	-50.8%
Operating Income	-$92M	-$68M	-35.8%
Net Income	-$82M	-$59M	-39.0%